hurdles to car-t therapy for mds & aml: t-cell fitness & lack of a uniform target antigen
Published 1 year ago • 302 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:04
the major hurdles and emerging opportunities of car t-cell therapy
-
1:53
the impact of t-cell fitness on patient response to car-t therapy
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:38
challenges of car-t therapy in the real-world setting
-
3:43
the future of car-t therapy
-
2:05
the cost-effectiveness of car t-cell therapy
-
0:52
the future of car t-cell therapy for aml
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
0:37
hot topics in car t-cell therapy for all
-
3:33
an overview of the car t-cell therapy story
-
1:29
settings for car t-cell therapy
-
1:53
how can we improve car t-cell therapy?
-
2:53
safety and efficacy of allogenic car-t cell treatment
-
1:29
settings for car t-cell therapy
-
2:13
regulatory hurdles in car t-cell therapy roll-out
-
0:59
the clinical implementation of car t-cell therapy
-
3:22
dealing with the rapid progress in car-t therapies
-
4:15
impacts and effects of car t-cell therapy for pediatric all